FDA takes aim at Hims and other telehealth services in drug advertising blitz

The Food and Drug Administration on Tuesday posted more than 100 letters to various drug and online prescribing companies, including Hims & Hers, which has built a multibillion-dollar business centered around lower-cost versions of blockbuster obesity injections. The FDA warned the company to remov...

Redirecting to full article...